Edgewise Therapeutics Inc (EWTX) — Financial Flexibility Index

Latest as of March 2026: -1.67x

Edgewise Therapeutics Inc (EWTX) has a Financial Flexibility Index of -1.67x as of March 2026. Free cash flow of $-42.28 Million (operating CF $-42.54 Million minus capex $260.00K) represents -2% of total liabilities ($25.32 Million). Check Edgewise Therapeutics Inc (EWTX) tangible net worth to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-1.67x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-42.28 Million
Operating CF − Capex

Total Liabilities

$25.32 Million
USD

Capital Expenditures

$260.00K
USD

Edgewise Therapeutics Inc Financial Flexibility Index (2019–2025)

Historical Financial Flexibility Index trend for Edgewise Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see EWTX operating cash flow.

Annual Financial Flexibility Index for Edgewise Therapeutics Inc (2019–2025)

Year-by-year free cash flow to debt coverage for Edgewise Therapeutics Inc. Explore EWTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -4.73x $-143.56 Million $-143.82 Million $30.35 Million ▼ -21.2%
2024 -3.90x $-107.72 Million $-109.03 Million $27.60 Million ▲ +4.0%
2023 -4.07x $-86.20 Million $-91.95 Million $21.20 Million ▼ -76.0%
2022 -2.31x $-47.09 Million $-52.63 Million $20.39 Million ▲ +23.7%
2021 -3.03x $-32.84 Million $-33.51 Million $10.85 Million ▼ -3351.3%
2020 -0.09x $-14.43 Million $-14.63 Million $164.56 Million ▲ +59.6%
2019 -0.22x $-8.99 Million $-9.17 Million $41.39 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities